Skip to main content
OpenTrials
Completed

NCT Number: NCT01204879

Reinforcing Exercise in Substance Abusing Patients

This study will evaluate the efficacy of an exercise-based contingency management (CM) intervention. A total of 120 substance abusing patients in intensive outpatient treatment will be randomly assigned to one of two conditions: (a) standard care plus CM for completing goal-related activities not related to exercising (e.g., improving work, family, or transportation issues), or (b) standard care plus CM for completing exercise-related activities. Compared to those receiving goal-related CM activity contracting, it is expected that those in the exercise CM condition will participate in more physical activities and develop greater strength and flexibility, decrease drug use, reduce HIV risk behaviors, lessen depressive symptoms, and improve health indices.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Substance Abuse Behavior Chemically-Induced Disorders Contingency Management Exercise Mental Disorders Motor Activity Substance-Related Disorders

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Alcohol and Drug Recovery Centers, Inc.

Hartford, Connecticut, 60112, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • age 18-65 years
  • English speaking
  • in substance abuse treatment
  • written permission from a physician (or their designated health care professional, e.g., nurse, physicians assistant) to participate in the study and an exercise program.

Exclusion criteria

  • inability to comprehend the study
  • in recovery for pathological gambling
  • contraindication for exercising

Treatment and study plan

Contingency Management

Behavioral

Participants earn the chance to win prizes for the targeted behavior.

Primary outcomes

  1. physical activity participation and functioning measured by the PAQ (Kcal/wk expenditures)

    Time frame: baseline

  2. physical activity participation and functioning measured by the PAQ (Kcal/wk expenditures)

    Time frame: month 2

  3. physical activity participation and functioning measured by the PAQ (Kcal/wk expenditures)

    Time frame: month 4

  4. physical activity participation and functioning measured by the PAQ (Kcal/wk expenditures)

    Time frame: month 6

  5. physical activity participation and functioning measured by the PAQ (Kcal/wk expenditures)

    Time frame: month 9

  6. physical activity participation and functioning measured by the PAQ (Kcal/wk expenditures)

    Time frame: month 12

  7. attendance at exercise classes

    Time frame: baseline

  8. attendance at exercise classes

    Time frame: month 2

  9. attendance at exercise classes

    Time frame: month 4

  10. attendance at exercise classes

    Time frame: month 6

  11. attendance at exercise classes

    Time frame: month 9

  12. attendance at exercise classes

    Time frame: month 12

Secondary outcomes

  1. longest duration of abstinence

    Time frame: baseline

  2. longest duration of abstinence

    Time frame: month 2

  3. longest duration of abstinence

    Time frame: month 4

  4. longest duration of abstinence

    Time frame: month 6

  5. longest duration of abstinence

    Time frame: month 9

  6. longest duration of abstinence

    Time frame: month 12

  7. HIV risk behaviors as reported on HRBS questionnaire

    Time frame: baseline

  8. HIV risk behaviors as reported on HRBS questionnaire

    Time frame: month 2

  9. HIV risk behaviors as reported on HRBS questionnaire

    Time frame: month 4

  10. HIV risk behaviors as reported on HRBS questionnaire

    Time frame: month 6

  11. HIV risk behaviors as reported on HRBS questionnaire

    Time frame: month 9

  12. HIV risk behaviors as reported on HRBS questionnaire

    Time frame: month 12

  13. psychological distress as reported on BSI questionnaire

    Time frame: baseline

  14. psychological distress as reported on BSI questionnaire

    Time frame: month 2

  15. psychological distress as reported on BSI questionnaire

    Time frame: month 4

  16. psychological distress as reported on BSI questionnaire

    Time frame: month 6

  17. psychological distress as reported on BSI questionnaire

    Time frame: month 9

  18. psychological distress as reported on BSI questionnaire

    Time frame: month 12

Sponsors and collaborators

Lead sponsor

UConn Health

Other

Collaborators

  • National Institute on Drug Abuse (NIDA)

Registry information

Important dates

Study start
2010
Primary completion
2015
Study completion
2015
First posted
Sep 17, 2010
Registry last updated
Jun 26, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.